These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26441207)

  • 1. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Ooft ML; Braunius WW; Heus P; Stegeman I; van Diest PJ; Grolman W; Zuur CI; Willems SM
    Biomark Med; 2015; 9(10):997-1010. PubMed ID: 26441207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
    Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: A meta-analysis.
    Ma X; Huang J; Wu X; Li X; Zhang J; Xue L; Li P; Liu L
    Cancer Biomark; 2014; 14(4):267-77. PubMed ID: 24934370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.
    Sun W; Long G; Wang J; Mei Q; Liu D; Hu G
    Head Neck; 2014 Oct; 36(10):1508-16. PubMed ID: 23996630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
    Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.
    Zheng LS; Yang JP; Cao Y; Peng LX; Sun R; Xie P; Wang MY; Meng DF; Luo DH; Zou X; Chen MY; Mai HQ; Guo L; Guo X; Shao JY; Huang BJ; Zhang W; Qian CN
    Cancer Res; 2017 Jan; 77(2):579-589. PubMed ID: 27671677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.
    He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z
    Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
    Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling.
    Hu WJ; Liu J; Zhong LK; Wang J
    Biomed Pharmacother; 2018 Jun; 102():681-688. PubMed ID: 29604587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
    Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
    Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR.
    Kim TJ; Lee YS; Kang JH; Kim YS; Kang CS
    J Surg Oncol; 2011 Jan; 103(1):46-52. PubMed ID: 21031415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Targeted degradation of epidermal growth factor receptor in nasopharyngeal carcinoma by chimeric molecule].
    Dong J; Li S; Wang Q; Xiao W; Yin SC
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):297-300. PubMed ID: 29871246
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A systematic review and meta-analysis.
    Liu F; Jin T; Liu L; Xiang Z; Yan R; Yang H
    PLoS One; 2018; 13(3):e0194733. PubMed ID: 29566078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 71 patients and analysis of the prognostic factors].
    Sun X; Liu J; Wang H; Yu H; Wang J; Li H; Gu Y; Guo L; Wang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 50(11):890-5. PubMed ID: 26887992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.
    Lin Q; Wang H; Lin X; Zhang W; Huang S; Zheng Y
    Cancer Biother Radiopharm; 2018 Mar; 33(2):60-64. PubMed ID: 29634414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of cyclo-oxygenase-2 predicts poor survival of patients with nasopharyngeal carcinoma: a meta-analysis.
    Sim CC; Sim EU
    J Laryngol Otol; 2020 Apr; 134(4):338-343. PubMed ID: 32172705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.